AG
CMD

Aperio Group’s Cantel Medical Corporation CMD Stock Holding History

Aperio Group’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$671K Sell
8,512
-452
-5% -$26.5K ﹤0.01% 1822
2020
Q3 		$394K Buy
8,964
+759
+9% +$37.4K ﹤0.01% 1947
2020
Q2 		$363K Sell
8,205
-517
-6% -$19.3K ﹤0.01% 1940
2020
Q1 		$313K Sell
8,722
-1,929
-18% -$110K ﹤0.01% 1881
2019
Q4 		$755K Sell
10,651
-217
-2% -$15.7K ﹤0.01% 1593
2019
Q3 		$813K Sell
10,868
-105
-1% -$8.9K ﹤0.01% 1504
2019
Q2 		$885K Buy
10,973
+938
+9% +$66K ﹤0.01% 1462
2019
Q1 		$671K Sell
10,035
-1,242
-11% -$94.1K ﹤0.01% 1576
2018
Q4 		$840K Sell
11,277
-1,362
-11% -$112K ﹤0.01% 1403
2018
Q3 		$1.16M Sell
12,639
-212
-2% -$20.2K 0.01% 1322
2018
Q2 		$1.26M Sell
12,851
-1,572
-11% -$176K 0.01% 1245
2018
Q1 		$1.61M Buy
14,423
+259
+2% +$29K 0.01% 1093
2017
Q4 		$1.46M Buy
14,164
+270
+2% +$26.9K 0.01% 1124
2017
Q3 		$1.31M Buy
13,894
+1,075
+8% +$84.8K 0.01% 1133
2017
Q2 		$999K Buy
12,819
+1,262
+11% +$94.8K 0.01% 1239
2017
Q1 		$926K Buy
11,557
+1,279
+12% +$102K 0.01% 1207
2016
Q4 		$809K Sell
10,278
-61
-0.6% -$4.74K 0.01% 1230
2016
Q3 		$806K Buy
10,339
+478
+5% +$34.7K 0.01% 1207
2016
Q2 		$678K Sell
9,861
-306
-3% -$21.1K 0.01% 1245
2016
Q1 		$726K Buy
10,167
+2,122
+26% +$133K 0.01% 1193
2015
Q4 		$500K Buy
8,045
+506
+7% +$30.9K ﹤0.01% 1336
2015
Q3 		$427K Buy
7,539
+241
+3% +$12.8K ﹤0.01% 1387
2015
Q2 		$392K Buy
7,298
+635
+10% +$30.9K ﹤0.01% 1467
2015
Q1 		$316K Buy
6,663
+489
+8% +$21.6K ﹤0.01% 1538
2014
Q4 		$267K Buy
+6,174
New +$252K ﹤0.01% 1583

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
LGP
Leonard Green & Partners Los Angeles, California $2.77B AUM 3.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return

Aperio Group's CMD Position: Q4 2020 in Review

Aperio Group reduced its Cantel Medical Corporation (CMD) stake by 5% in Q4 2020, selling an estimated $26.5K and leaving 8,512 shares worth $671K. The position accounts for ﹤0.01% of the portfolio, ranked #1822.

Aperio Group first reported a position in CMD in Q4 2014 and has held it in 25 quarters since. The position peaked at $1.61M in Q1 2018. 229 funds tracked by Wall St. Rank hold CMD as of Q4 2020.

  • Aperio Group held 8,512 shares of Cantel Medical Corporation worth $671K as of Q4 2020.
  • Aperio Group sold 452 Cantel Medical Corporation shares in Q4 2020, an estimated $26.5K.
  • Cantel Medical Corporation made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #1822 holding.
  • Aperio Group first reported a position in Cantel Medical Corporation in Q4 2014 and has held it in 25 quarters since.
  • Aperio Group's Cantel Medical Corporation position peaked at $1.61M in Q1 2018.
  • 229 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.